Trevor Beattie
Trevor Beattie publishes mostly in Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine, on topics such as Tuberculosis Research and Epidemiology, Pneumocystis jirovecii pneumonia detection and treatment and HIV/AIDS drug development and treatment.
- World rank
- #1,861,357 of 7,710,434 ranked researchers
- Rank in South Africa
- #7,839 of 29,826
- Works
- 16
- Citations
- 352
- Citations per work
- 22.0
What does Trevor Beattie research?
Trevor Beattie's work is mostly in Medicine (77%), Immunology and Microbiology (5%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1276.8%
- Medicine1276.8%
- Everything else316.2%
- Life Sciences17.0%
- 1Infectious Diseases44% of their works
- 2Epidemiology19% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Surgery5% of their works
- 5Immunology5% of their works
- 6Molecular Medicine2% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS drug development and treatment
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Chronic Obstructive Pulmonary Disease (COPD) Research
Which keywords describe Trevor Beattie's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Drug Resistance, Immune Response, Vaccine, Mycobacterium tuberculosis and Tuberculosis.
- spike protein
- Pneumococcal Conjugate Vaccine
- Mycobacterium avium
- Community-Acquired Pneumonia
- COPD
- HIV Infection
- Pneumonia
- ACE2 Receptor
- Tuberculosis
- Vaccine
- Drug Resistance
- Diagnosis
- Epidemiology
- Treatment
- Immune Response
- Mycobacterium tuberculosis
- Antiretroviral Therapy
- Pneumocystis
- SARS-CoV-2
- Integrase Inhibitors
- Clinical Characteristics
- Coronavirus
- Nontuberculous Mycobacteria
- Thrombosis
- spirometry
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Epidemiology205 topics
- Diagnosis184 topics
- Treatment163 topics
- Drug Resistance132 topics
- Immune Response122 topics
- Vaccine122 topics
- Mycobacterium tuberculosis101 topic
- Tuberculosis101 topic
- Antiretroviral Therapy72 topics
- ACE2 Receptor42 topics
- Pneumocystis41 topic
- Pneumonia41 topic
- SARS-CoV-242 topics
- HIV Infection31 topic
- Integrase Inhibitors31 topic
- COPD21 topic
- Clinical Characteristics21 topic
- Community-Acquired Pneumonia21 topic
- Coronavirus21 topic
- Mycobacterium avium21 topic
- Nontuberculous Mycobacteria21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Thrombosis21 topic
- spike protein21 topic
- spirometry21 topic
Where does Trevor Beattie work?
Trevor Beattie's main affiliation in the publication record is Aurum Institute, South Africa.
How many publications and citations does Trevor Beattie have?
OpenAlex counts 16 works and 352 citations for Trevor Beattie, an h-index of 7, ranking #1,861,357 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Trevor Beattie. Posts are plain text and can be reported.